Standout Papers

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting 2006 2026 2012 2019 1.7k
  1. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting (2006)
    Christine Esau, Scott Davis et al. Cell Metabolism
  2. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice (2014)
    Thazha P. Prakash, Mark J. Graham et al. Nucleic Acids Research

Immediate Impact

16 by Nobel laureates 22 from Science/Nature 144 standout
Sub-graph 1 of 14

Citing Papers

Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras
2023 StandoutScienceNobel
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid
2023 Standout
3 intermediate papers

Works of Sheri Booten being referenced

Ligand Conjugated Antisense Oligonucleotide for the Treatment of Transthyretin Amyloidosis: Preclinical and Phase 1 Data
2020
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy
2012
and 1 more

Author Peers

Author Last Decade Papers Cites
Sheri Booten 2292 306 488 1500 28 3.3k
Chris Schindler 2269 275 367 919 30 6.5k
Christian Stockmann 1980 254 323 1579 35 5.2k
Christina Warnecke 2113 228 279 2242 44 4.3k
Friedemann Horn 3206 210 334 1587 81 6.3k
Concetta Bubici 2216 116 332 1087 29 3.7k
F. Michael Yakes 3406 221 336 670 20 5.8k
Heehyoung Lee 2875 196 360 1504 25 5.8k
Benjamin D. Hopkins 2872 393 320 903 41 4.3k
Stéphane Plaisance 2817 247 255 1491 48 5.8k
Igor Vivanco 4930 560 329 1266 28 6.9k

All Works

Loading papers...

Rankless by CCL
2026